Novartis AG is 56.8x more valuable than LIGAND PHARMACEUTICALS INC by market capitalization ($282.64 B vs $4.97 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LGND | NVS |
|---|---|---|
| Market cap | $4.97 B | $282.64 B |
| US-listed rank | #1389 | #47 |
| Revenue (latest FY) | $268.09M | - |
| Net income (latest FY) | $124.45M | - |
| Net margin | 46.4% | - |
| P/E (trailing FY) | 40.0 | - |
| SEC filings | 2,226 | 947 |
Novartis AG is 56.8x more valuable than LIGAND PHARMACEUTICALS INC by market capitalization ($282.64 B vs $4.97 B).
Full pages: LIGAND PHARMACEUTICALS INC and Novartis AG, or browse the full rankings.